{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:03:02Z","timestamp":1767772982947},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,7]]},"DOI":"10.7759\/cureus.16982","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T19:20:24Z","timestamp":1628364024000},"source":"Crossref","is-referenced-by-count":5,"title":["COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Ahtesham","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moazma","family":"Ramzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aftab","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anam","family":"Ahtesham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seemal","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeria","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij PE","year":"2020","unstructured":"Verweij PE, Rijnders BJ, Br\u00fcggemann RJ, et al.. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020, 46:1524-35. 10.1007\/s00134-020-06091-6","journal-title":"Intensive Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe AF","year":"2018","unstructured":"Schauwvlieghe AF, Rijnders BJ, Philips N, et al.. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018, 6:782-92. 10.1016\/S2213-2600(18)30274-1","journal-title":"Lancet Respir Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler P","year":"2020","unstructured":"Koehler P, Cornely OA, B\u00f6ttiger BW, et al.. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020, 63:528-34. 10.1111\/myc.13096","journal-title":"Mycoses"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment","volume":"6","author":"Arastehfar A","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, et al.. COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi (Basel). 2020, 6:91. 10.3390\/jof6020091","journal-title":"J Fungi (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa242","article-title":"Invasive aspergillosis as an under-recognized superinfection in COVID-19","volume":"7","author":"Thompson Iii GR","year":"2020","unstructured":"Thompson Iii GR, Cornely OA, Pappas PG, et al.. Invasive aspergillosis as an under-recognized superinfection in COVID-19. Open Forum Infect Dis. 2020, 7:ofaa242. 10.1093\/ofid\/ofaa242","journal-title":"Open Forum Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/cc12836","article-title":"CD8\u207a T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis","volume":"17","author":"Cui N","year":"2013","unstructured":"Cui N, Wang H, Long Y, Liu D. CD8\u207a T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis. Crit Care. 2013, 17:R157. 10.1186\/cc12836","journal-title":"Crit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13213","article-title":"Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity","volume":"64","author":"Machado M","year":"2021","unstructured":"Machado M, Valerio M, \u00c1lvarez-Ur\u00eda A, et al.. Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity. Mycoses. 2021, 64:132-43. 10.1111\/myc.13213","journal-title":"Mycoses"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford BJ","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, et al.. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020, 26:1622-9. 10.1016\/j.cmi.2020.07.016","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio A","year":"2020","unstructured":"Alanio A, Delli\u00e8re S, Fodil S, Bretagne S, M\u00e9garbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020, 8:e48-9. 10.1016\/S2213-2600(20)30237-X","journal-title":"Lancet Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel AL","year":"2020","unstructured":"van Arkel AL, Rijpstra TA, Belderbos HN, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020, 202:132-5. 10.1164\/rccm.202004-1038LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10100807","article-title":"Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature","volume":"10","author":"Apostolopoulou A","year":"2020","unstructured":"Apostolopoulou A, Esquer Garrigos Z, Vijayvargiya P, Lerner AH, Farmakiotis D. Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature. Diagnostics (Basel). 2020, 10:807. 10.3390\/diagnostics10100807","journal-title":"Diagnostics (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00486-8","article-title":"Epidemiology and incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in a Greek tertiary care academic reference hospital","volume":"10","author":"Paramythiotou E","year":"2021","unstructured":"Paramythiotou E, Dimopoulos G, Koliakos N, Siopi M, Vourli S, Pournaras S, Meletiadis J. Epidemiology and incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in a Greek tertiary care academic reference hospital. Infect Dis Ther. 2021, 10:1779-92. 10.1007\/s40121-021-00486-8","journal-title":"Infect Dis Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study (Epub ahead of print)","author":"Bartoletti M","year":"2020","unstructured":"Bartoletti M, Pascale R, Cricca M, et al.. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study (Epub ahead of print). Clin Infect Dis. 2020, 10.1093\/cid\/ciaa1065","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13135","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan","volume":"63","author":"Nasir N","year":"2020","unstructured":"Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan. Mycoses. 2020, 63:766-70. 10.1111\/myc.13135","journal-title":"Mycoses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler P","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, et al.. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021, 21:e149-62. 10.1016\/S1473-3099(20)30847-1","journal-title":"Lancet Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis MS","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003, 362:1828-38. 10.1016\/S0140-6736(03)14904-5","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman W","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007, 45:205-16. 10.1086\/518852","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"van de Veerdonk FL","year":"2017","unstructured":"van de Veerdonk FL, Kolwijck E, Lestrade PP, et al.. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2017, 196:524-7. 10.1164\/rccm.201612-2540LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2021.01.002","article-title":"Tocilizumab administration in COVID-19 patients: water on the fire or gasoline?","volume":"31","author":"Deana C","year":"2021","unstructured":"Deana C, Vetrugno L, Bassi F, De Monte A. Tocilizumab administration in COVID-19 patients: water on the fire or gasoline?. Med Mycol Case Rep. 2021, 31:32-4. 10.1016\/j.mmcr.2021.01.002","journal-title":"Med Mycol Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.02.034","article-title":"IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity","volume":"140","author":"Cunha C","year":"2017","unstructured":"Cunha C, Gon\u00e7alves SM, Duarte-Oliveira C, et al.. IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J Allergy Clin Immunol. 2017, 140:867-70. 10.1016\/j.jaci.2017.02.034","journal-title":"J Allergy Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert L","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, et al.. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020, 10:71. 10.1186\/s13613-020-00686-4","journal-title":"Ann Intensive Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers JA","year":"2014","unstructured":"McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014, 12:252-62. 10.1038\/nrmicro3231","journal-title":"Nat Rev Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40278-021-94618-0","article-title":"Dexamethasone\/tocilizumab: herpes virus reactivation and COVID-19-associated pulmonary Aspergillosis secondary to off label use: case report","volume":"1852","author":"Deana C","year":"2021","unstructured":"Deana C. Dexamethasone\/tocilizumab: herpes virus reactivation and COVID-19-associated pulmonary Aspergillosis secondary to off label use: case report. Reactions Weekly. 2021, 1852:165. 10.1007\/s40278-021-94618-0","journal-title":"Reactions Weekly"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab163","article-title":"Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA) (Epub ahead of print)","author":"Lamoth F","year":"2021","unstructured":"Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DP. Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA) (Epub ahead of print). J Infect Dis. 2021, 10.1093\/infdis\/jiab163","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115274","article-title":"Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"99","author":"Wu Z","year":"2021","unstructured":"Wu Z, Wang L, Tan L, Wu J, Chen Z, Hu M. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagn Microbiol Infect Dis. 2021, 99:115274. 10.1016\/j.diagmicrobio.2020.115274","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65426-covid-associated-pulmonary-aspergillosis-and-its-related-outcomes-a-single-center-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:00Z","timestamp":1707507180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65426-covid-associated-pulmonary-aspergillosis-and-its-related-outcomes-a-single-center-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.16982","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,7]]}}}